QBM076

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QBM076, covering 2016-03-24 to 2016-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076. [Phase 2]

See pricing